Most recent update: Thursday, December 12, 2019 - 11:42

Bariatric News - Cookies & privacy policy

You are here

Ethicon acquisition

Ethicon to acquire Linx GERD system with Torax acquisition

Torax Medical offers Linx reflux management system for the treatment of gastroesophageal reflux disease (GERD)

Ethicon has announced a definitive agreement to acquire Torax Medical, medical device company that manufactures and markets the Linx Reflux Management System, a minimally-invasive device for the surgical treatment of gastroesophageal reflux disease (GERD). The acquisition of Torax Medical will enable Ethicon to offer patients a safe and effective alternative to the anatomy-altering laparoscopic Nissen fundoplication surgical procedure.

This Linx Reflux Management System is a small implant comprised of interlinked titanium beads with magnetic cores which augment the body’s natural barrier function to prevent reflux. The magnetic attraction between the beads helps the lower oesophageal sphincter (LOS) resist opening to gastric pressures, preventing reflux from the stomach into the oesophagus. Swallowing forces temporarily break the magnetic bond, allowing food and liquid to pass normally into the stomach. Magnetic attraction closes the LOS immediately after swallowing, restoring the body’s natural barrier to reflux.

Linx is currently used by physicians in over 300 hospitals in the US and Europe. This acquisition is consistent with Ethicon’s strategy of advancing innovation and investing in areas of unmet medical needs such as oesophageal health.

Financial terms of the transaction have not been disclosed. The closing of the transaction is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions. The transaction is expected to close during the first quarter of 2017.

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.